Gapping down
In reaction to disappointing earnings/guidance:
- XLNX -8.2% (also announces 7% global workforce reduction), CHRW -8.2% (also will acquire Prime Distribution for $225 mln), EBAY -5.2%, AMD -4.7%, ADP -3.4%, ANTM -2.9%, SLAB -2.1%, EAT -2%, TRMK -1.8%, RXN -1.6%, ALK -1.4%, IR -1.3%, MKTX -1.3%, LFUS -1.2%, SBUX -1%, BXP -0.7%, SKY -0.6%, BXP -0.6%, T -0.6%, MCD -0.5%
Other news:
- BHVN -11% (prices underwritten public offering of 4,830,917 of its common shares at a price to the public of $51.75 per share)
- CERS -3.6% (commences $50 mln public offering)
- DNLI -3.6% (prices offering of 7,826,087 shares of common stock at $23.00 per share)
- AMPH -3.4% (FDA issued a "MINOR" Complete Response Letter for its ANDA for Epinephrine Injection)
- ESTA -3.4% (commences $55 mln stock offering)
Analyst comments:
- GLP -2.1% (downgraded to Underweight from Neutral at JP Morgan)
- CPRI -2.1% (downgraded to Hold at Needham on low visibility)
- CAL -1.2% (downgraded to Hold at Needham on low visibility for 2020)
- NUE -1% (downgraded to Underweight from Neutral at JP Morgan)